Web Content Viewer (JSR 286)

USDA proposes changes to Virus-Serum-Toxin Act to provide clearer information about biologic products

Archives

http://www.regulations.gov/#!documentDetail;D=APHIS-2011-0049-0010 

Summary

We are proposing to amend the Virus-Serum-Toxin Act regulations to provide for the use of a simpler labeling format that would better communicate product performance to the user. We intend to replace the current label format, which reflects any of four different levels of effectiveness, with a single, uniform label format. We are also proposing to require biologics licensees to provide a standardized summary, with confidential business information removed, of the efficacy and safety data submitted to the Animal and Plant Health Inspection Service in support of the issuance of a full product license or conditional license. A simpler label format along with publicly available safety and efficacy data will help biologics producers to more clearly communicate product performance to their customers.



Additional Information